COCA COLA CO annual report, FY2019

Business context and reporting period

The Coca-Cola Company’s Form 10-K covers the fiscal year ended December 31, 2019; it is an annual report, not a standalone fourth-quarter filing. Coca-Cola markets more than 500 beverage brands in over 200 countries and territories, primarily through independent bottling partners. The company reported results across six operating segments: Europe, Middle East and Africa; Latin America; North America; Asia Pacific; Global Ventures; and Bottling Investments.

Financial performance and position

• Revenue rose 9%; reported worldwide unit-case and concentrate-sales volume each grew 2%. Revenue growth reflected favorable price, product and geographic mix (+5 percentage points) and acquisitions and divestitures (+7 points), partly offset by foreign exchange (-4 points).
• Operating income increased 10%, supported by volume, pricing and mix, productivity savings, lower other operating charges and acquisitions; currency effects were unfavorable. The effective tax rate was 16.7%, versus 21.3% in 2018.
• Operating cash flow increased 37%, which management attributed partly to operating improvement, working-capital management and extended supplier payment terms. Capital expenditures were $2.054 billion; operating cash flow less capital expenditures was approximately $8.417 billion, an arithmetic cash-flow measure rather than a company-defined metric.
• Cash, cash equivalents, short-term investments and marketable securities totaled $11.2 billion at year-end; available general-purpose backup credit lines were $8.9 billion. Current liabilities of $26.973 billion exceeded current assets of $20.411 billion; management nevertheless characterized liquidity as strong.
• Dividends paid were $6.845 billion. The 2019 annual dividend was $1.60 per share; in February 2020, the board raised the quarterly dividend to $0.41 per share, or $1.64 annualized.

Material changes versus the prior comparable period

• Revenue rose from $34.300 billion to $37.266 billion, while net income attributable to shareowners rose from $6.434 billion to $8.920 billion. The comparison reflects acquisitions, divestitures and significant nonrecurring items, not solely underlying growth.
• Gross margin fell 1.1 percentage points, mainly due to structural changes and unfavorable currency effects; the company notes finished-product operations generally have lower gross margins than concentrate operations.
• Net cash from operations increased by $2.844 billion. Cash and cash equivalents declined to $6.480 billion from $9.077 billion; cash, short-term investments and marketable securities combined declined to $11.2 billion from $16.1 billion.
• The company acquired Costa in January 2019 for $4.9 billion net of cash acquired and acquired the remaining interest in CHI. It also acquired or consolidated certain bottling operations and refranchised bottling territories. Costa contributed to higher revenue and Global Ventures results.
• Long-term debt increased to $27.516 billion from $25.376 billion, while the company continued substantial debt issuance and repayment activity.

Outlook, commentary, risks and unusual items

• Management expected 2020 acquisitions and divestitures to have a slightly favorable effect on revenue and foreign currencies to have a slightly unfavorable effect on revenue and operating income. It expected an approximately 19.5% effective tax rate, about $2.0 billion in capital expenditures and substantial operating cash flow.
• As of the filing date, management expected COVID-19 disruption, primarily in China, to reduce first-quarter 2020 volume and financial results, but did not expect a significant full-year 2020 impact. The filing stresses uncertainty about duration and broader effects; this outlook was made before subsequent developments.
• Significant 2019 items included a $739 million gain on sale of a New York retail and office building; $767 million of other-than-temporary impairments of equity-method investments; a $160 million reduction to CCBA asset values; a $118 million loss on acquiring the remaining CHI interest; and a $42 million trademark impairment. Other operating charges totaled $458 million, including $264 million for productivity and reinvestment initiatives.
• The IRS tax dispute for 2007–2009 involves a potential additional federal tax liability of approximately $3.3 billion plus interest. The company disputes the IRS position; the Tax Court trial had concluded and final briefs were filed, but no opinion had issued. An adverse outcome could be material, and the IRS could propose similar adjustments for later years.
• Key disclosed risks include changing consumer preferences and health concerns about sugar, beverage taxes and regulation; intense competition; water availability and quality; agricultural and packaging supply and cost pressures; plastic-packaging regulation and reputation; currency movements; bottler financial health; cybersecurity and privacy; and litigation and impairment risk.
• In January 2020, after year-end, Coca-Cola acquired the remaining 57.5% of fairlife for $1.0 billion, with additional milestone payments contingent on performance through 2024. Purchase accounting was not finalized in the filing.
• The auditor issued an unqualified opinion on the financial statements and internal controls. Critical audit matters included uncertain tax positions and valuation of indefinite-lived trademarks and goodwill.

Important facts for investors to verify

• How much of 2019 revenue and earnings growth came from organic volume and pricing versus Costa and other structural changes, currency, and one-time gains or charges.
• The status, potential exposure and financial-statement treatment of the $3.3 billion IRS dispute, including possible interest and any later-year assessments.
• Whether the 2020 COVID-19 outlook, particularly the expected limited full-year impact, remained valid as conditions evolved.
• Debt maturities, refinancing needs and liquidity after the decline in cash and marketable securities, supplier-payment extensions and the fairlife acquisition.
• Fairlife’s final purchase-price allocation and contingent milestone payments, and Costa’s performance relative to acquisition assumptions.
• Underlying earnings and investment exposures at equity-method bottlers, given 2019 impairment charges and the company’s reliance on bottling partners.